Enlarged Prostate (Benign Prostatic Hyperplasia)

What is Enlarged Prostate?

An enlarged prostate, medically known as benign prostatic hyperplasia (BPH), is a non‑cancerous increase in the size of the prostate gland. The prostate is a small, walnut‑shaped organ located just below the bladder in men. It surrounds the urethra—the tube that carries urine out of the body. As the gland grows, it can compress the urethra and interfere with normal urinary flow.

BPH is common: studies show that about 50 % of men have some degree of prostate enlargement by age 60, and up to 90 % by age 85. Despite the high prevalence, many men remain asymptomatic. When symptoms develop, they can affect quality of life but are usually treatable.

Common Causes

While the exact trigger for prostate cells to proliferate is not fully understood, several factors are consistently linked to BPH development:

• Age – Hormonal changes after middle age stimulate prostatic growth.
• Androgen hormones – Dihydrotestosterone (DHT) derived from testosterone promotes cell division in the prostate.
• Estrogen imbalance – Higher relative estrogen levels in older men can enhance prostate tissue growth.
• Family history – Men with a father or brother who had BPH are at higher risk.
• Obesity – Excess adipose tissue increases peripheral conversion of testosterone to estrogen.
• Metabolic syndrome – Diabetes, high blood pressure, and dyslipidemia have been linked to larger prostate volumes.
• Inflammation – Chronic prostatitis or recurring urinary tract infections may stimulate hyperplasia.
• Medications – Long‑term use of certain drugs (e.g., antihistamines, decongestants) can worsen urinary symptoms.
• Dietary factors – High intake of red meat and saturated fat may increase risk, while a diet rich in fruits, vegetables, and omega‑3 fatty acids appears protective.
• Lifestyle – Sedentary habits and excessive alcohol consumption have been associated with larger prostates.

Associated Symptoms

Symptoms arise from the prostate’s pressure on the urethra and the bladder’s response to incomplete emptying. Commonly reported signs include:

• Frequent need to urinate, especially at night (nocturia).
• Urgency— a sudden, strong urge to urinate.
• Difficulty starting the stream (hesitancy) or a weak urinary stream.
• Dribbling at the end of urination.
• Feeling that the bladder is not completely empty.
• Intermittent stream— urine flow starts and stops.
• Straining to begin urination.
• Occasional urinary leakage.

Most men with BPH experience a combination of these “lower urinary tract symptoms” (LUTS). In many cases, symptoms are mild and progress slowly over years.

When to See a Doctor

While occasional urinary changes are common with aging, prompt medical evaluation is warranted if any of the following occur:

• Sudden worsening of urinary frequency or urgency.
• Persistent painful burning during urination.
• Blood in the urine (hematuria) or semen.
• Inability to urinate at all (acute urinary retention).
• Recurring urinary tract infections.
• Significant impact on sleep or daily activities.

If you notice any of these signs, schedule an appointment with a primary‑care physician or urologist. Early assessment can prevent complications such as bladder stones, kidney damage, or chronic infections.

Diagnosis

Evaluation of an enlarged prostate combines a detailed history, physical examination, and targeted tests.

1. Medical History & Symptom Scores

Doctors often ask about the frequency, severity, and timing of urinary symptoms. The International Prostate Symptom Score (IPSS) is a standardized questionnaire that quantifies symptom burden and guides treatment decisions.

2. Digital Rectal Exam (DRE)

The clinician inserts a gloved, lubricated finger into the rectum to feel the prostate’s size, shape, and consistency. A smooth, enlarged gland suggests BPH, whereas hard nodules may raise suspicion for prostate cancer.

3. Laboratory Tests

• Prostate‑specific antigen (PSA) – Elevated PSA can be seen in BPH, infection, or cancer; results help decide if further evaluation is needed.
• Urinalysis – Checks for infection, blood, or glucose.

4. Imaging & Flow Studies

• Transrectal ultrasound (TRUS) – Provides accurate measurement of prostate volume.
• Uroflowmetry – Records urine flow rate; a reduced peak flow suggests obstruction.
• Post‑void residual (PVR) measurement – Ultrasound or bladder scanner quantifies urine left after voiding.

5. Cystoscopy (if needed)

In selected cases, a thin camera is passed through the urethra to visualize the bladder and prostate opening. This is usually reserved for men with severe symptoms or when another cause is suspected.

Treatment Options

Management is individualized based on symptom severity, prostate size, overall health, and patient preference. Options range from lifestyle modifications to surgery.

1. Watchful Waiting (Active Surveillance)

Men with mild symptoms and minimal impact on quality of life can be monitored with periodic PSA testing and symptom scores. Lifestyle changes (see below) often provide sufficient relief.

2. Medications

• Alpha‑blockers (e.g., tamsulosin, alfuzosin) – Relax smooth muscle in the prostate and bladder neck, improving urine flow within hours to days.
• 5‑alpha‑reductase inhibitors (e.g., finasteride, dutasteride) – Decrease DHT levels, gradually shrinking the gland over 6–12 months.
• Combination therapy – Using an alpha‑blocker plus a 5‑alpha‑reductase inhibitor offers better symptom control for larger prostates.
• Phosphodiesterase‑5 inhibitors (e.g., tadalafil) – May improve both urinary symptoms and erectile function, especially in men with concurrent erectile dysfunction.

Medication side effects (e.g., dizziness, decreased libido, ejaculatory problems) should be discussed with your doctor.

3. Minimally Invasive Procedures

• Transurethral microwave thermotherapy (TUMT) – Uses heat to ablate excess prostate tissue.
• Transurethral needle ablation (TUNA) – Radiofrequency energy destroys small portions of the prostate.
• UroLift® System – Permanent implants mechanically lift and hold open the obstructed urethra without cutting tissue.
• Prostatic artery embolization (PAE) – Interventional radiology technique that reduces blood flow to the prostate, causing it to shrink.

These procedures generally have shorter recovery times than traditional surgery and preserve sexual function.

4. Surgical Options

• Transurethral resection of the prostate (TURP) – Gold‑standard surgery that removes obstructive prostate tissue via a resectoscope.
• Laser enucleation (HoLEP, GreenLight® laser) – Uses laser energy to excise or vaporize prostate tissue, offering less bleeding and faster catheter removal.
• Open or robot‑assisted prostatectomy – Reserved for very large glands (>80–100 mL) or when other methods are unsuitable.

All surgical approaches carry risks such as bleeding, infection, urinary incontinence, or retrograde ejaculation. Discuss benefits and drawbacks with a urologist.

5. Home & Lifestyle Measures

• Limit fluid intake 2–4 hours before bedtime to reduce nocturia.
• Avoid caffeine, alcohol, and carbonated drinks that irritate the bladder.
• Practice double‑voiding (urinate, wait a few minutes, then try again) to empty the bladder more completely.
• Maintain a healthy weight and engage in regular aerobic exercise.
• Pelvic floor (Kegel) exercises can improve bladder control for some men.

Prevention Tips

Because BPH is largely age‑related, complete prevention is impossible, but the following strategies may delay onset or lessen severity:

• Adopt a plant‑rich diet – Foods high in lycopene (tomatoes), selenium (Brazil nuts), and omega‑3s (fish) are associated with smaller prostate volume.
• Stay active – At least 150 minutes of moderate‑intensity exercise per week improves hormonal balance and reduces obesity‑related risk.
• Maintain a healthy weight – Even modest weight loss can lower estrogen conversion and improve urinary symptoms.
• Limit intake of saturated fats and red meat – High‑fat diets may accelerate prostatic growth.
• Stay hydrated, but avoid bladder irritants – Water is essential, but cut back on caffeine and spicy foods if they worsen urgency.
• Regular medical check‑ups – Annual PSA testing and DRE (as recommended by your clinician) help catch changes early.
• Manage chronic conditions – Control diabetes, hypertension, and cholesterol to reduce metabolic‑syndrome contribution.

Emergency Warning Signs

If you experience any of the following, seek emergency medical care (call 911 or go to the nearest emergency department):

• Sudden inability to urinate (acute urinary retention).
• Severe, continuous pain in the lower abdomen or pelvic region.
• Fever > 100.4 °F (38 °C) with chills—possible severe urinary infection.
• Blood clots in the urine or a large amount of blood.
• Rapid onset of confusion or weakness—possible kidney failure from prolonged retention.

---

**References**

• Mayo Clinic. “Benign prostatic hyperplasia (BPH).” https://www.mayoclinic.org. Accessed May 2026.
• Cleveland Clinic. “BPH (Enlarged Prostate) Treatment.” https://my.clevelandclinic.org. Accessed May 2026.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Benign Prostatic Hyperplasia.” https://www.niddk.nih.gov. Accessed May 2026.
• American Urological Association. “Guideline for the Management of Benign Prostatic Hyperplasia.” 2022 Update.
• World Health Organization. “Non‑communicable diseases: Men’s health.” 2023.